Dokter Vincent Eggerding
ActiveDokter Vincent Eggerding has been active since 2022 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €297k and a net result of €216k. Equity is growing by ~42.7% per year across the filed fiscal years. Its solvency ranks better than 55% of 16527 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
Checked score
Score 2025
94
/ 100
Excellent
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability100=
Solvency94▼-6
Growth78=
Track record94
Bankruptcy probability, 12 months
0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €25k at 30 days acceptable
Liquidity ample (current ratio 2.9 against 4.43 in 2024; short-term debt: 29.4% and cash: 65.1% of total assets), and 31.2% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Six signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Sector 86
lower
← fewer bankruptcies
more bankruptcies →
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
68.8%
Return on assets
50.1%
Age of the figures
9 mo
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 28-07-2026, 3 days ahead of the deadline.
NBB · 4 filingsDeviation from the deadline
2025
3 d early
2024
7 d early
2023
30 d late
2022
31 d late
← before the deadline
after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
22-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, micro schema
Equity
€297k▼ 18.9%
2024 · €366k
2022: €58k
2023: €183k
2024: €366k
2022 → 2025
Total assets
€432k▼ 9.2%
2024 · €475k
2022: €114k
2023: €252k
2024: €475k
2022 → 2025
Net result
€216k▲ 18.3%
2024 · €183k
2022: €53k
2023: €125k
2024: €183k
2022 → 2025
Working capital
€241k▼ 24.3%
2024 · €318k
2022: €62k
2023: €163k
2024: €318k
2022 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line2022202320242025Trend
Equity€58k-€183k▲ 216%€366k▲ 99.9%€297k▼ 18.9%
Operating result€67k-€161k▲ 140%€229k▲ 42.5%€276k▲ 20.6%
Net result€53k-€125k▲ 136%€183k▲ 46.2%€216k▲ 18.3%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result has risen three years in a row; 2025 is 21% above 2024 and is the highest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €432k
Fixed assets
€64k▼ 0.8%
Current assets
€367k▼ 10.5%
Equity and liabilities €432k
Equity
€297k▼ 18.9%
Debt
€135k▲ 23.6%
The debt ratio rises from 22.9% to 31.2%. Equity is lower and debt is higher.
Key figures and ratios
EBITDA
€285k▲
2024 · €233k
Cash flow
€224k▲
2024 · €187k
Solvency
68.8%▼
2024 · 77.1%
Current ratio
2.90▼
2024 · 4.43
Quick ratio
2.90▼
2024 · 4.43
Debt / equity
0.45▲
2024 · 0.30
ROE
72.9%▲
2024 · 50.0%
ROA
50.1%▲
2024 · 38.5%
Interest coverage
83.10▼
2024 · 111.82
Debt
€135k▲
2024 · €109k
Debt ≤ 1 year
€127k▲
2024 · €93k
Income taxes
€68k▲
2024 · €55k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet
Code20242025
Assets
Total assets20/58€475k€432k▼
Fixed assets21/28€65k€64k▼
Tangible fixed assets22/27€65k€64k▼
Plant, machinery and equipment23€4k€3k▼
Other tangible fixed assets26€60k€61k▲
Current assets29/58€410k€367k▼
Amounts receivable within one year40/41€248k€82k▼
Trade receivables40€58k€82k▲
Other amounts receivable41€191k-
Cash at bank and in hand54/58€162k€281k▲
Deferred charges and accrued income490/1-€5k
Equity and liabilities
Total equity and liabilities10/49€475k€432k▼
Equity10/15€366k€297k▼
Contributions10/11€5k€5k=
Reserves13€361k€292k▼
Distributable reserves133€361k€292k▼
Amounts payable17/49€109k€135k▲
Amounts payable within one year42/48€93k€127k▲
Current portion of amounts payable after more than one year42-€20k
Trade debts44€2k€1k▼
Suppliers440/4€2k€1k▼
Taxes, remuneration and social security45€90k€106k▲
Taxes450/3€90k€106k▲
Accrued charges and deferred income492/3€16k€8k▼
Income statement
Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€4k€8k▲
Other operating charges640/8€490€485▼
Gross operating margin9900€233k€285k▲
Operating profit (loss)9901€229k€276k▲
Financial income75/76B€11k€11k▲
Recurring financial income75€11k€11k▲
Financial charges65/66B€2k€3k▲
Recurring financial charges65€2k€3k▲
Profit (loss) for the period before taxes9903€238k€284k▲
Income taxes67/77€55k€68k▲
Profit (loss) for the period9904€183k€216k▲
Profit (loss) for the period to be appropriated9905€183k€216k▲
Appropriation of the result
Profit (loss) to be appropriated9906€183k€216k▲
Transfer from equity791/2-€69k
Transfer to equity691/2€183k-
To other reserves6921€183k-
Profit to be distributed694/7-€286k
Return on contributions (dividend)694-€286k
The notes to these accounts (5 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
28-07
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema
2025
31-12
Financial
Highest result since 2022net €216k ▲18.3%
Operating result €276k, net result €216k, both a record.
24-07
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
2024
31-12
Financial
Equity above €200kEq €366k ▲99.9%
3 profitable years in a row build equity to €366k.
30-08
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema · 30 days late
2023
31-12
Financial
Equity above €150kEq €183k ▲216%
2 profitable years in a row build equity to €183k.
31-08
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema · 31 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
2 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, De Haan · 1 establishment unit since 2022
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Westhinderlaan 668420 De HaanGround area
590 m²
Building footprint
141 m²
Volume, LiDAR
712 m³
Parcel 31038B0213/00F000, Flanders · tallest building 8.5 m, ±2 floors. Linked by address, not a title deed.
1 establishment unit
Dokter Vincent Eggerding
since 20222.327.598.637
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 31038B0213/00F000 | Flanders | 590 m² | 1 · 141 m² | 8.5 m · 2 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
Dr Ponchon
BE 0502.588.870
Overijse · Eq €297k
CEO MEDICAL
BE 0475.798.856
Oudergem · Eq €297k
Dr. Erik Ranschaert
BE 0668.403.838
Turnhout · Eq €297k
SAUKAMED
BE 0696.839.486
Mechelen · Eq €297k
SOMNOLUTIONS
BE 0720.555.491
Merchtem · Eq €297k
Of 16,628 companies in sector 86220 we hold annual accounts for 7,973. 6,663 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded28-01-2022
Fiscal year end31-12
Activities, NACEBEL
86220Specialist medical practice
Sources
Crossroads Bank for EnterprisesNational Bank · 4 filingsAddress and cadastre registers
Data from official sources, last processed on 22-09-2026. Scores and ratios are computed by Checked and are not a credit decision.